To date, targeting glutamine metabolism enzymes, such as glutaminase (GLS1, an enzyme that restricts the conversion of glutamine to glutamate and its cataplerotic entry into the TCA cycle), in combination with chemotherapy is promising for suppressing tumor growth141,142. Here, GLS is linked to neoplasm.